Oropouche virus (OROV) is one of the most common arboviruses that infect humans in Brazil. It is estimated that since the first isolation of the virus in 1955, it has affected more than half a million people. However, it is probably often mistakenly diagnosed as Dengue, Zika or Chikungunya virus, and therefore true levels of infection are unclear.
We offer a range of Oropouche antigens to aid in the development of assays to reliably detect the infection.
Oropouche virus background
Oropouche virus (OROV) is an RNA virus that belongs to the family Bunyaviridae. Phylogenetic analysis of OROV has identified 4 virus genotypes (I, II, III, IV), which all occur in Brazil. In humans, OROV causes Oropouche fever, which is clinically characterized by a rapid-onset acute febrile illness. Oropouche fever is reported to be the second most common arboviral disease, next to Dengue fever, in the Brazilian Amazon region. Other symptoms associated with the disease are like those reported for Dengue, Zika, chikungunya, yellow fever and include headache, myalgia, joint pain, nausea and vomiting. In some cases, OROV can cause a type of viral meningitis.
In humans, OROV is transmitted by the biting midge culicoides paraensis, an insect vector that lives in urban areas and is widely distributed in South America. Since the virus was first isolated in 1955, OROV has caused 30 large scale epidemics in the Amazon region infecting at least 500,000 people. The incidence of Oropouche fever has now become widespread in Latin American countries where c.paraensis is present.
Given the geographical spread of OROV and the similarity of the symptoms of Oropouche fever to infections caused by Dengue, Zika, Chikungunya and Yellow Fever viruses, it is important to be able to differentiate diagnostically between these arboviral diseases.
- World Health Organization (WHO). Oropouche Virus disease – Peru. http://www.who.int/csr/don/03-june-2016-oropouche-peru/en/
- Vasconcelos, H.B. et al (2011). Molecular epidemiology of Oropouche virus, Brazil. Emerg Infect Dis. 17:800-6
- Sakkas, H. et al (2018) Oropouche Fever: A Review Viruses 10:175
In support of work to enhance the study of Oropouche infection, we offer a range of antigens that are relevant for immunoassay and vaccine research. These include Gc and Gn glycoprotiens, expressed in our mammalian cell system, and the non-glycosylated Nucleoprotein expressed in E.Coli.
Check out our FAQ section for answers to the most frequently asked questions about our website and company.